<![CDATA[Pharma — November 2023]]>Lundbeck: Positive data fra fase 3 forsøg med Alzheimers-middel https://www.proinvestor.com/investornyt/1075006/lundbeck-positive-data-fra-fase-3-forsog-med-alzheimers-middel

]]>https://dev.proinvestor.com/forum/topic/400880/pharma-november-2023RSS for NodeSun, 07 Jun 2026 04:31:44 GMTMon, 06 Nov 2023 16:11:08 GMT60<![CDATA[Reply to Pharma — November 2023 on Wed, 29 Nov 2023 08:30:01 GMT]]>Ambu får europæisk godkendelse for urinrørsskopi-produkt
29.11.2023 10.27 • MarketWire •
Kopier link til udklipsholderen
Ambu får europæisk godkendelse af sit nye ureteroskopi-produkt, der blandt andet bruges til undersøgelse af nyre- eller urinrørssten.
Det fremgår af en pressemeddelelse fra Ambu onsdag formiddag.

Ambus nye ureteroskopiløsning bestående af det fleksible engangsureteroskop Ascope 5 Uretero, og full-HD endoskopisystemet Aboxtm 2 er blevet godkendt af de europæiske myndigheder.

]]>https://dev.proinvestor.com/forum/post/8037950https://dev.proinvestor.com/forum/post/8037950Wed, 29 Nov 2023 08:30:01 GMT<![CDATA[Reply to Pharma — November 2023 on Tue, 28 Nov 2023 05:26:12 GMT]]>God morgen 🙂

]]>https://dev.proinvestor.com/forum/post/8037946https://dev.proinvestor.com/forum/post/8037946Tue, 28 Nov 2023 05:26:12 GMT<![CDATA[Reply to Pharma — November 2023 on Mon, 27 Nov 2023 05:47:26 GMT]]>Godmorgen 🙂

]]>https://dev.proinvestor.com/forum/post/8037947https://dev.proinvestor.com/forum/post/8037947Mon, 27 Nov 2023 05:47:26 GMT<![CDATA[Reply to Pharma — November 2023 on Fri, 24 Nov 2023 14:15:41 GMT]]>3 Healthcare Stocks to Scoop Up as They Change the Medical Landscape https://www.proinvestor.com/investornyt/1082446/3-healthcare-stocks-to-scoop-up-as-they-change-the-medical-landscape

]]>https://dev.proinvestor.com/forum/post/8037949https://dev.proinvestor.com/forum/post/8037949Fri, 24 Nov 2023 14:15:41 GMT<![CDATA[Reply to Pharma — November 2023 on Mon, 20 Nov 2023 08:52:23 GMT]]>Efter stort fald: Novos hjerte-kar-data har medvirket til comeback i flere sundhedsaktier https://www.proinvestor.com/investornyt/1081157/efter-stort-fald-novos-hjerte-kar-data-har-medvirket-til-comeback-i-flere-sundhedsaktier

]]>https://dev.proinvestor.com/forum/post/8037943https://dev.proinvestor.com/forum/post/8037943Mon, 20 Nov 2023 08:52:23 GMT<![CDATA[Reply to Pharma — November 2023 on Sun, 19 Nov 2023 07:21:32 GMT]]>Eli Lilly klar til første spadestik for tysk fabrik for 2,5 mia. dollar https://www.proinvestor.com/investornyt/1080520/eli-lilly-klar-til-forste-spadestik-for-tysk-fabrik-for-25-mia-dollar

]]>https://dev.proinvestor.com/forum/post/8037945https://dev.proinvestor.com/forum/post/8037945Sun, 19 Nov 2023 07:21:32 GMT<![CDATA[Reply to Pharma — November 2023 on Fri, 17 Nov 2023 19:36:05 GMT]]>Hvad synes folk om Coloplast for tiden?

]]>https://dev.proinvestor.com/forum/post/8037939https://dev.proinvestor.com/forum/post/8037939Fri, 17 Nov 2023 19:36:05 GMT<![CDATA[Reply to Pharma — November 2023 on Wed, 15 Nov 2023 06:39:55 GMT]]>Alk-Abello: Bedre end ventet på alle poster. Er vækstcasen endegyldigt tilbage på sporet? https://www.proinvestor.com/boards/116732

]]>https://dev.proinvestor.com/forum/post/8037942https://dev.proinvestor.com/forum/post/8037942Wed, 15 Nov 2023 06:39:55 GMT<![CDATA[Reply to Pharma — November 2023 on Wed, 15 Nov 2023 06:31:25 GMT]]>ALK-Abelló har tocifret vækst i tabletsalget i Europa i tredje kvartal https://www.proinvestor.com/investornyt/1079227/alk-abello-har-tocifret-vaekst-i-tabletsalget-i-europa-i-tredje-kvartal

]]>https://dev.proinvestor.com/forum/post/8037938https://dev.proinvestor.com/forum/post/8037938Wed, 15 Nov 2023 06:31:25 GMT<![CDATA[Reply to Pharma — November 2023 on Wed, 15 Nov 2023 05:58:35 GMT]]>ALK-Abelló Q3: Europæisk tabletsalg er kommet op i omdrejninger
15.11.2023 07.40 • MarketWire •

ALK-Abelló har klaret sig bedre end ventet målt på såvel indtjening som omsætning i tredje kvartal, hvor tabletsalget i Europa har overrasket positivt.

Det fremgår af kvartalsregnskabet.

]]>https://dev.proinvestor.com/forum/post/8037940https://dev.proinvestor.com/forum/post/8037940Wed, 15 Nov 2023 05:58:35 GMT<![CDATA[Reply to Pharma — November 2023 on Tue, 14 Nov 2023 06:29:33 GMT]]>Lundbeck får sænket anbefaling og skåret kursmål hos britisk storbank

Lundbeck får sænket anbefaling og skåret kursmål hos britisk storbank https://www.proinvestor.com/investornyt/1078575/lundbeck-far-saenket-anbefaling-og-skaret-kursmal-hos-britisk-storbank

]]>https://dev.proinvestor.com/forum/post/8037944https://dev.proinvestor.com/forum/post/8037944Tue, 14 Nov 2023 06:29:33 GMT<![CDATA[Reply to Pharma — November 2023 on Tue, 14 Nov 2023 04:54:53 GMT]]>Lundbeck får indledt dækning hos Morgan Stanley med "undervægt" https://www.proinvestor.com/investornyt/1078568/lundbeck-far-indledt-daekning-hos-morgan-stanley-med-undervaegt

]]>https://dev.proinvestor.com/forum/post/8037941https://dev.proinvestor.com/forum/post/8037941Tue, 14 Nov 2023 04:54:53 GMT<![CDATA[Reply to Pharma — November 2023 on Mon, 13 Nov 2023 03:56:14 GMT]]>Is Bristol Myers Squibb Stock Undervalued At $50? https://www.proinvestor.com/investornyt/1078042/is-bristol-myers-squibb-stock-undervalued-at-50

]]>https://dev.proinvestor.com/forum/post/8037937https://dev.proinvestor.com/forum/post/8037937Mon, 13 Nov 2023 03:56:14 GMT<![CDATA[Reply to Pharma — November 2023 on Thu, 09 Nov 2023 08:14:29 GMT]]>AstraZeneca Reaches Obesity Drug Deal; Imfinzi Combination Meets Main Goal In Liver Cancer Trial https://www.proinvestor.com/investornyt/1076681/astrazeneca-reaches-obesity-drug-deal-imfinzi-combination-meets-main-goal-in-liver-cancer-trial

]]>https://dev.proinvestor.com/forum/post/8037948https://dev.proinvestor.com/forum/post/8037948Thu, 09 Nov 2023 08:14:29 GMT